Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar Parobek (28.46) Submitted: 2/08/08 8:41 PM : Outperform Start Price: $13.60 ALKS Score: 8.58

Week #2 - Tuesday: 'Stock Pick of the Day'

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links